Tuesday, 9 October 2018

Questions (344)

Michael Harty


344. Deputy Michael Harty asked the Minister for Health the progress of the rare diseases medical product technology review committee; the drugs that have been referred to it by the HSE; the way in which it is scheduling or prioritising the review of each drug; the number of drugs it expects to review in 2018; the timelines associated with reviewing medicines; and if he will make a statement on the matter. [41125/18]

View answer

Written answers (Question to Health)

As the question refers to the National Rare Disease Technology Review Committee it has been referred to the HSE for direct reply to the Deputy.